← FDA Drug Approvals (Drugs@FDA)
ESOMEPRAZOLE MAGNESIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2020-06-25
Drug application
- FDA Application #
ANDA212088- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ESOMEPRAZOLE MAGNESIUM
- Generic name
- ESOMEPRAZOLE MAGNESIUM
- Active ingredients
- ESOMEPRAZOLE MAGNESIUM
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- MYLAN
- Manufacturer
- CVS Pharmacy
- First approval
- 2020-06-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown